Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660242 · ClinicalTrials.gov registry record · Phase 2
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
A Phase 2 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT02660242 is a Phase 2 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 16 participants.
The verdict
NCT02660242, a Phase 2 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
This project focuses on development of new strategy for the prevention of exercise-associated hypoglycemia using mini-dose glucagon.
Interventions
- DRUG G-Pen Mini™ (glucagon injection)
- OTHER Glucose Tabs
- OTHER Basal Insulin Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-02-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02660242
The ClinicalTrials.gov registry entry for NCT02660242 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which G-Pen Mini™ (glucagon injection) is the first listed.
NCT02660242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02660242 about?
NCT02660242 is a clinical study titled "The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes". This project focuses on development of new strategy for the prevention of exercise-associated hypoglycemia using mini-dose glucagon.
What is the current status of trial NCT02660242?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2016-01. Estimated completion is 2017-02-15.
What interventions are being tested in trial NCT02660242?
The interventions under investigation include: G-Pen Mini™ (glucagon injection) (DRUG), Glucose Tabs (OTHER), Basal Insulin Reduction (OTHER).
Who is sponsoring clinical trial NCT02660242?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.